SLEEP AND MENTAL HEALTH DURING THE COVID-19 PANDEMIC: FINDINGS FROM AN ONLINE QUESTIONNAIRE SURVEY IN CHINA




Production and persistence of specific antibodies in COVID-19 patients with hematologic malignancies: role of rituximab

Abstract The ability of patients with hematologic malignancies (HM) to develop an effective humoral immune response after COVID-19 is unknown.A prospective study was performed to monitor the immune response to SARS-CoV-2 of patients with follicular lymphoma (FL), diffuse large B-cell lymphoma (DLBCL), chronic lymphoproliferative disorders (CLD), mu

read more